The Institute for Clinical and Economics Review (ICER) announced Monday, May 20, that it is developing two new tools aimed at streamlining stakeholders’ ability to examine the organization’s “entire body of work” to bolster decision-making.
ICER made the announcement during the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) annual meeting in New Orleans, Louisiana.
The organization in a press release said the new cloud-based platforms will enable stakeholders to more quickly “generate actionable summaries, allowing them to more readily use this work in a variety of strategic decisions.”
“Our Evidence Compendium and Interactive Modeler will significantly expand and expedite all stakeholders’ ability to access key details across a wide collection of past ICER assessments, and to tailor modeling inputs and assumptions based on a specific patient population or existing cost structure,” ICER President Steven Pearson said.
Click here to learn more about ICER’s new tools.
To learn more about ISPOR’s annual meeting in New Orleans, click here.
